Roche begins Phase III clinical trial of Actemra in hospitalised patients with severe COVID-19 pneumonia Medical Dialogues Bureau20 March 2020 10:00 AM ISTBasel: Roche has announced that it is working with the Food & Drug Administration (FDA) to initiate a randomised, double-blind, placebo-controlled...
NPPA, regularly monitoring situations of prices and availability of essentials medicines, says Minister Medical Dialogues Bureau19 March 2020 3:15 PM ISTDelhi: The Minister for Chemicals & Fertilizers Shri. D.V. Sadananda Gowda informed the Lok Sabha in written reply today that NPPA is...
CDSCO lays down the Timeline for testing of various classes of New drugs Medical Dialogues Bureau19 March 2020 2:33 PM ISTNew Delhi: To streamline the process of testing for approval of all categories of drugs, the Central Drugs Standard Control Organization(CDSCO),...
Lilly Receives FDA Breakthrough Therapy Designation for Baricitinib for Alopecia Areata Medical Dialogues Bureau19 March 2020 12:56 PM ISTBaricitinib is currently approved for the treatment of adults with moderately to severely active rheumatoid arthritis (RA).
Cipla joins hands with CSIR-IICT to develop coronavirus drug Medical Dialogues Bureau19 March 2020 12:10 PM ISTHyderabad: Hyderabad-based CSIR-Indian Institute of Chemical Technology (IICT) has tied up with pharmaceutical giant Cipla to work on the...
Pfizer, Biontech join hands to co-develop mRNA-based coronavirus vaccine Medical Dialogues Bureau19 March 2020 11:00 AM ISTNew York & Mainz: Pfizer Inc.and BioNTech SE has announced that the companies have agreed to a letter of intent regarding the co-development and...
Emami share buyback size likely to be Rs 900-1000 crore Medical Dialogues Bureau19 March 2020 9:00 AM ISTKolkata: The size of proposed buyback of shares by Emami Ltd is likely to be in the range of Rs 900-1,000 crore, sources said on Monday. The promoters...
NPPA orders Surgical, Protective Masks makers, importers to provide data Medical Dialogues Bureau18 March 2020 5:26 PM ISTDelhi: Through a recent Office Memorandum National Pharmaceutical Pricing Authority(NPPA), Ministry of Chemicals & Fertilizers has ordered all the...
Price fixation of drugs saves Rs 12,447 crores per annum, says NPPA data Medical Dialogues Bureau18 March 2020 2:46 PM ISTNational Pharmaceutical Pricing Authority (NPPA), as an ongoing process, fixes the ceiling prices of the formulations as and when formulations are...
Regeneron, Sanofi begin testing use of Arthritis Drug Kevzara to treat COVID-19 Medical Dialogues Bureau18 March 2020 12:24 PM ISTKevzara is a fully-human monoclonal antibody that inhibits the interleukin-6 (IL-6) pathway by binding and blocking the IL-6 receptor.The use of...
Alembic Pharma gets USFDA EIR for API Facility at Karakhadi Medical Dialogues Bureau18 March 2020 12:00 PM ISTGujrat: Alembic Pharmaceuticals Limited has announced that it has received Establishment Inspection Report (EIR) from US Food and Drug Administration...
Dr Reddy's Labs launches Ziprasidone Mesylate for Injection in US Market Medical Dialogues Bureau18 March 2020 10:00 AM ISTHyderabad and Princeton: Dr Reddy's Laboratories Ltd. has announced the launch of Ziprasidone Mesylate for Injection, 20 mg (base)/mL Single-dose...
